Galán Burgos, Miguel
531  Ergebnisse:
Personensuche X
?
3

Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to C..:

Gaibar Alonso, María ; Galán Burgos, Miguel ; Romero Lorca, Alicia...
Gaibar, M., Galán, M., Romero-Lorca, A., Antón, B., Malón, D., Moreno, A., . & Novillo, A. (2021). Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer. International Journal of Molecular Sciences, 22(3), 1381. https://doi.org/10.3390/ijms22031381.  , 2021
 
?
4

Role of Chromodomain-Helicase-DNA-Binding protein 4 (CHD4) ..:

Novillo Villajos, Apolonia ; Fernández Santander, Ana ; Gaibar Alonso, María...
Novillo, A., Fernández-Santander, A., Gaibar, M., Galán, M., Romero-Lorca, A., El Abdellaoui-Soussi, F., & Gómez-del Arco, P. (2021). Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer. Frontiers in Oncology, (11), 1196. https://doi.org/10.3389/fonc.2021.633233.  , 2021
 
?
5

Efficacy of bevacizumab-containing chemotherapy in metastat..:

Novillo Villajos, Apolonia ; Gaibar Alonso, María ; Romero Lorca, Alicia...
Novillo, A., Gaibar, M., Romero-Lorca, A., Fuencisla Gilsanz, M., Beltrán, L., Galán, M., Antón, B., Malón, D., Moreno, A., & Fernández-Santander, A. (2020). Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports. World Journal of Gastroenterology, 26(16), 1979–1986. https://doi.org/10.3748/wjg.v26.i16.1979.  , 2020
 
?
7

Prognostic value of the immune target CEACAM6 in cancer: a ..:

Burgos, Miguel ; Cavero-Redondo, Iván ; Álvarez-Bueno, Celia...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592110726 , 2022
 
?
 
1-15